We are live on ! Find out more
EXAS icon

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

548 hedge funds and large institutions have $8.11B invested in Exact Sciences in 2022 Q4 according to their latest regulatory filings, with 124 funds opening new positions, 167 increasing their positions, 165 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more funds holding in top 10

Funds holding in top 10: 1 → 6 (+5)

148% more first-time investments, than exits

New positions opened: 124 | Existing positions closed: 50

15% more capital inflows, than outflows

Capital inflows: $653M | Capital outflows: $569M

14% more funds holding

Funds holding: 481 → 548 (+67)

1% more repeat investments, than reductions

Existing positions increased: 167 | Existing positions reduced: 165

0.56% more ownership

Funds ownership: 91.58% → 92.13% (+0.56%)

3% less call options, than puts

Call options by funds: $123M | Put options by funds: $127M

Holders
548
Holders Change
+67
Holders Change %
+13.93%
% of All Funds
8.78%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.1%
New
124
Increased
167
Reduced
165
Closed
50
Calls
$123​M
Puts
$127​M
Net Calls
-⁠$4.01​M
Net Calls Change
-⁠$10.1​M

EXAS Hedge Fund Activity: Q4 2022 in Review

548 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2022, worth a combined $8.11B — up 54% from $5.27B a quarter earlier.

Buyers outnumbered sellers: 124 funds opened new EXAS positions and 50 closed out — a net gain of 74 holders — while 167 added to existing stakes and 165 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $127M. The largest seller was ARK Investment Management, cutting an estimated $62.2M.

  • 548 institutional investors held Exact Sciences (EXAS) as of Q4 2022, up from 481 in Q3 2022.
  • Funds reported $8.11B of Exact Sciences stock for Q4 2022, up 54% quarter-over-quarter.
  • 124 funds opened new Exact Sciences positions in Q4 2022 and 50 closed out, a net change of +74 holders.
  • The largest Exact Sciences buyer in Q4 2022 was JP Morgan Chase, an estimated $127M added.
  • The largest Exact Sciences seller in Q4 2022 was ARK Investment Management, an estimated $62.2M sold.

Based on aggregated 13F filings for Q4 2022.